OA06599A - Procédé de préparation d'un agent pour le traitement de théilérioses. - Google Patents

Procédé de préparation d'un agent pour le traitement de théilérioses.

Info

Publication number
OA06599A
OA06599A OA57198A OA57198A OA06599A OA 06599 A OA06599 A OA 06599A OA 57198 A OA57198 A OA 57198A OA 57198 A OA57198 A OA 57198A OA 06599 A OA06599 A OA 06599A
Authority
OA
OAPI
Prior art keywords
theileroses
agent
preparation
treatment
Prior art date
Application number
OA57198A
Other languages
English (en)
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA06599A publication Critical patent/OA06599A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA57198A 1979-08-23 1980-08-22 Procédé de préparation d'un agent pour le traitement de théilérioses. OA06599A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792934069 DE2934069A1 (de) 1979-08-23 1979-08-23 Mittel gegen theileriosen und seine verwendung.

Publications (1)

Publication Number Publication Date
OA06599A true OA06599A (fr) 1981-08-31

Family

ID=6079087

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57198A OA06599A (fr) 1979-08-23 1980-08-22 Procédé de préparation d'un agent pour le traitement de théilérioses.

Country Status (14)

Country Link
US (1) US4340596A (cs)
BE (1) BE884917A (cs)
CH (1) CH649545A5 (cs)
DE (1) DE2934069A1 (cs)
EG (1) EG14600A (cs)
FR (2) FR2468368A1 (cs)
GB (1) GB2057439B (cs)
IL (1) IL60890A (cs)
KE (1) KE3382A (cs)
MA (1) MA18939A1 (cs)
MW (1) MW3080A1 (cs)
OA (1) OA06599A (cs)
ZM (1) ZM6780A1 (cs)
ZW (1) ZW19680A1 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1155358B (it) * 1982-07-06 1987-01-28 Vetem Spa Derivati chinazolinonici attivi contro la coccidiosi
US5017567A (en) * 1983-11-25 1991-05-21 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4906635A (en) * 1983-11-25 1990-03-06 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4778795A (en) * 1983-11-25 1988-10-18 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4762838A (en) * 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
US4797486A (en) * 1986-09-08 1989-01-10 Pfizer Inc. Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents
DE3638445A1 (de) * 1986-11-11 1988-05-26 Hoechst Ag Coccidiozide mittel
US4849518A (en) * 1987-06-22 1989-07-18 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
US4920224A (en) * 1988-03-24 1990-04-24 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
WO1993014753A1 (en) * 1992-01-27 1993-08-05 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
US5998422A (en) * 1994-12-12 1999-12-07 Agricultural Research Organization, Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
IL112125A (en) * 1994-12-22 1998-02-08 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
US6090814A (en) * 1995-08-15 2000-07-18 Agricultural Research Organization Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
CA2253362C (en) * 1996-08-30 2003-05-06 Arnon Nagler Intracoronary stents containing quinazolinone derivatives
US6028075A (en) * 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
US6159488A (en) * 1997-08-14 2000-12-12 Agricultural Research Org. Ministry Of Agriculture (Gov.) Intracoronary stents containing quinazolinone derivatives
AU756437B2 (en) * 1998-08-13 2003-01-16 Agricultural Research Organization, Ministry Of Agricultural, State Of Israel Inhibition of pathogenic processes related to tissue trauma
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
JP2008531547A (ja) * 2005-02-23 2008-08-14 コルガード バイオファーマシューティカルズ リミテッド キナゾリノン誘導体であるハロフジノンの単離されたｄ−エナンチオマーの医薬組成物
WO2007120606A2 (en) * 2006-04-10 2007-10-25 President And Fellows Of Harvard College Methods for modulating formation and progression of cellulite
WO2009023267A2 (en) * 2007-08-15 2009-02-19 President And Fellows Of Harvard College Methods for modulating development and expansion of il-17 expressing cells
EP2331525A4 (en) * 2008-08-11 2013-01-02 Harvard College HALOFUGINONE ANALOGUE FOR INHIBITING TRNA SYNTHETASES AND APPLICATIONS THEREOF
WO2013106702A1 (en) 2012-01-13 2013-07-18 President And Fellows Of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
EP2845588A1 (en) * 2013-09-09 2015-03-11 Centre National de la Recherche Scientifique (C.N.R.S.) PIN1 inhibitors for use in the prevention and/or treatment of theileriosis, and related applications
WO2019237125A1 (en) 2018-06-08 2019-12-12 The General Hospital Corporation Inhibitors of prolyl-trna-synthetase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE505711A (cs) * 1950-09-09
US2694711A (en) * 1952-12-02 1954-11-16 American Cyanamid Co Quinazolone antimalarial compounds
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones

Also Published As

Publication number Publication date
GB2057439B (en) 1983-06-22
ZM6780A1 (en) 1981-10-21
DE2934069C2 (cs) 1990-02-15
FR2468602B1 (cs) 1983-07-22
CH649545A5 (de) 1985-05-31
ZW19680A1 (en) 1981-03-11
US4340596A (en) 1982-07-20
DE2934069A1 (de) 1981-03-12
KE3382A (en) 1984-03-23
IL60890A0 (en) 1980-10-26
IL60890A (en) 1983-09-30
GB2057439A (en) 1981-04-01
FR2468368B1 (cs) 1983-07-08
BE884917A (fr) 1981-02-25
EG14600A (en) 1985-03-31
FR2468368A1 (fr) 1981-05-08
MA18939A1 (fr) 1981-04-01
MW3080A1 (en) 1981-08-12
FR2468602A1 (fr) 1981-05-08

Similar Documents

Publication Publication Date Title
OA06599A (fr) Procédé de préparation d'un agent pour le traitement de théilérioses.
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
BE890648A (fr) Compositions pour le traitement de l'acne
OA06930A (fr) Procédé de préparation d'acides aza-bicyclo-octane carboxyliques.
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
OA06486A (fr) Procédé de préparation de 9 aminoalkylfluorènes.
OA06701A (fr) Procédé de traitement d'un phosphate aluminocalcique.
BE858590A (fr) Procede pour l'elimination de residus organiques radioactifs
OA07202A (fr) Procédé pour la préparation de l'urée
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
BE873092A (fr) Composition pour le traitement de l'hypertension
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
EP0092948A2 (en) Penicillin derivatives and process for preparation of the same.
BE858692A (fr) Composition pour le traitement de l'acne
BE867414A (fr) Procede pour la preparation d'hydroxy-alpha-aminobenzylpenicillines
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
OA06355A (fr) Procédé de préparation de 3-exométhylènecépham-sulfoxydes.
OA06284A (fr) Procédé de préparation de compositions pour le traitement d'infections chroniques de trypanosomiase.
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
BE867228A (fr) Procede pour la preparation d'hydroxyphenylglycocolles
BE880031A (fr) Procede pour la preparation de 1 alpha, 3 beta-dihydroxy-delta 5-steroides
OA06151A (fr) Procédé d'affinage des ferro-manganèses.